T. Rowe Price Associates’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $66.2M | Buy |
2,086,332
+46,627
| +2% | +$1.27M | 0.01% | 706 |
|
|
2025
Q4 | $55.4M | Sell |
2,039,705
-342,813
| -14% | -$9.03M | 0.01% | 788 |
|
|
2025
Q3 | $61.6M | Sell |
2,382,518
-1,435,302
| -38% | -$33.3M | 0.01% | 737 |
|
|
2025
Q2 | $77.7M | Buy |
3,817,820
+407,321
| +12% | +$7.93M | 0.01% | 621 |
|
|
2025
Q1 | $61.9M | Sell |
3,410,499
-146,637
| -4% | -$3.28M | 0.01% | 657 |
|
|
2024
Q4 | $89.9M | Buy |
3,557,136
+676,771
| +23% | +$18.4M | 0.01% | 587 |
|
|
2024
Q3 | $97.9M | Sell |
2,880,365
-292,034
| -9% | -$11.1M | 0.01% | 567 |
|
|
2024
Q2 | $117M | Buy |
3,172,399
+85,191
| +3% | +$3.21M | 0.01% | 513 |
|
|
2024
Q1 | $130M | Buy |
3,087,208
+2,664,915
| +631% | +$109M | 0.02% | 502 |
|
|
2023
Q4 | $16.7M | Sell |
422,293
-45,762
| -10% | -$1.35M | ﹤0.01% | 992 |
|
|
2023
Q3 | $12.9M | Sell |
468,055
-10,519
| -2% | -$330K | ﹤0.01% | 1020 |
|
|
2023
Q2 | $16.2M | Sell |
478,574
-234,988
| -33% | -$7.92M | ﹤0.01% | 990 |
|
|
2023
Q1 | $25.7M | Sell |
713,562
-119,447
| -14% | -$5.15M | ﹤0.01% | 850 |
|
|
2022
Q4 | $37.1M | Buy |
833,009
+87,001
| +12% | +$3.11M | 0.01% | 744 |
|
|
2022
Q3 | $21M | Buy |
746,008
+212,606
| +40% | +$6.52M | ﹤0.01% | 886 |
|
|
2022
Q2 | $14.4M | Sell |
533,402
-520,923
| -49% | -$15.1M | ﹤0.01% | 1249 |
|
|
2022
Q1 | $35.9M | Buy |
1,054,325
+138,717
| +15% | +$4.43M | ﹤0.01% | 1075 |
|
|
2021
Q4 | $35.4M | Buy |
915,608
+37,199
| +4% | +$1.62M | ﹤0.01% | 1121 |
|
|
2021
Q3 | $47.4M | Buy |
878,409
+489,361
| +126% | +$23M | ﹤0.01% | 1032 |
|
|
2021
Q2 | $13M | Buy |
389,048
+56,818
| +17% | +$1.56M | ﹤0.01% | 1383 |
|
|
2021
Q1 | $6.84M | Buy |
332,230
+39,162
| +13% | +$899K | ﹤0.01% | 1435 |
|
|
2020
Q4 | $5.13M | Buy |
+293,068
| New | +$5.27M | ﹤0.01% | 1435 |
|
|
2019
Q1 | – | Sell |
-7,027
| Closed | -$21K | – | 2535 |
|
|
2018
Q4 | $21K | Hold |
7,027
| – | – | ﹤0.01% | 2547 |
|
|
2018
Q3 | $48K | Hold |
7,027
| – | – | ﹤0.01% | 2568 |
|
|
2018
Q2 | $53K | Sell |
7,027
-37
| -0.5% | -$495 | ﹤0.01% | 2562 |
|
|
2018
Q1 | $247K | Buy |
7,064
+1,284
| +22% | +$49.8K | ﹤0.01% | 2355 |
|
|
2017
Q4 | $246K | Sell |
5,780
-3,977
| -41% | -$170K | ﹤0.01% | 2346 |
|
|
2017
Q3 | $419K | Buy |
9,757
+1,340
| +16% | +$50.2K | ﹤0.01% | 2154 |
|
|
2017
Q2 | $312K | Buy |
8,417
+434
| +5% | +$19.2K | ﹤0.01% | 2234 |
|
|
2017
Q1 | $432K | Buy |
7,983
+360
| +5% | +$18.7K | ﹤0.01% | 2123 |
|
|
2016
Q4 | $405K | Hold |
7,623
| – | – | ﹤0.01% | 2139 |
|
|
2016
Q3 | $462K | Buy |
7,623
+280
| +4% | +$17.4K | ﹤0.01% | 2048 |
|
|
2016
Q2 | $484K | Buy |
7,343
+2,386
| +48% | +$151K | ﹤0.01% | 1973 |
|
|
2016
Q1 | $281K | Buy |
4,957
+1,680
| +51% | +$189K | ﹤0.01% | 2181 |
|
|
2015
Q4 | $771K | Sell |
3,277
-106
| -3% | -$23.1K | ﹤0.01% | 1771 |
|
|
2015
Q3 | $535K | Buy |
3,383
+111
| +3% | +$31.4K | ﹤0.01% | 1919 |
|
|
2015
Q2 | $1.24M | Buy |
3,272
+237
| +8% | +$94.1K | ﹤0.01% | 1683 |
|
|
2015
Q1 | $1.27M | Hold |
3,035
| – | – | ﹤0.01% | 1672 |
|
|
2014
Q4 | $831K | Sell |
3,035
-429
| -12% | -$107K | ﹤0.01% | 1770 |
|
|
2014
Q3 | $673K | Buy |
3,464
+941
| +37% | +$205K | ﹤0.01% | 1832 |
|
|
2014
Q2 | $618K | Buy |
2,523
+300
| +13% | +$67.7K | ﹤0.01% | 1862 |
|
|
2014
Q1 | $589K | Hold |
2,223
| – | – | ﹤0.01% | 1855 |
|
|
2013
Q4 | $807K | Sell |
2,223
-447
| -17% | -$172K | ﹤0.01% | 1736 |
|
|
2013
Q3 | $1.42M | Sell |
2,670
-213
| -7% | -$73K | ﹤0.01% | 1607 |
|
|
2013
Q2 | $675K | Buy |
+2,883
| New | +$568K | ﹤0.01% | 1764 |
|
Other funds holding CLDX
KCM
VCM
CC
EP
